- Home
- FTRE vs AMAL Comparison
FTRE vs AMAL Comparison
Compare FTRE & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTRE | AMAL |
|---|---|---|
| Founded | 1996 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FTRE | AMAL |
|---|---|---|
| Price | $19.07 | $50.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | $14.06 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 1.5M | 145.5K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.99 |
| Revenue | ★ $2,723,400,000.00 | N/A |
| Revenue This Year | N/A | $21.18 |
| Revenue Next Year | $3.09 | $6.55 |
| P/E Ratio | ★ N/A | $25.03 |
| Revenue Growth | ★ 1.00 | N/A |
| 52 Week Low | $6.07 | $25.13 |
| 52 Week High | $21.39 | $50.92 |
Technical Indicators
Market Signals| Indicator | FTRE | AMAL |
|---|---|---|
| Relative Strength Index (RSI) | 55.93 | 67.24 |
| Support Level | $15.69 | $36.50 |
| Resistance Level | $21.39 | $50.92 |
| Average True Range (ATR) | 1.19 | 1.13 |
| MACD | -0.13 | 0.04 |
| Stochastic Oscillator | 42.54 | 83.61 |
Price Performance
Historical ComparisonAbout FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.